ALN-APOC3

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALN-APOC3, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: ALN-APOC3 in Adult Participants With Dyslipidemia [Phase 1]